Beyond humanization and de-immunization: tolerization as a method for reducing the immunogenicity of biologics by Sarah Moniz | Aug 15, 2018
T-cell dependent immunogenicity of protein therapeutics: Preclinical assessment and mitigation by Sarah Moniz | Aug 15, 2018
Augmented Binary Substitution: Single-pass CDR germ-lining and stabilization of therapeutic antibodies. by Sarah Moniz | Apr 10, 2018
Design, development and characterization of ACT017, a humanized Fab that blocks platelet’s glycoprotein VI function without causing bleeding risks. by Sarah Moniz | Apr 10, 2018
Generation and functional characterization of anti-human and anti-mouse IL-36R antagonist monoclonal antibodies. by Sarah Moniz | Apr 10, 2018
